Number of global sites doubled from 8 to 16
More countries integrated into international life sciences supply chains including USA, India and China
Westerville, Ohio (March 17, 2010) – Exel, in collaboration with its global sister organization, DHL Supply Chain, has strengthened its position as a leading North America Clinical Trials Logistics provider by adding depots in the United States and Canada . As part of its clinical trials service expansion, DHL Supply Chain has increased the number of global depots from 8 to 16 to also include India , China , Panama , Chile , Argentina and Lebanon . The company now offers its successful Clinical Trials Logistics (CTL) service across 64 countries worldwide. This expansion of expertise enables the leading logistics provider to service additional key research sites around the world, to integrate emerging markets into global supply chains and to strengthen customers’ global research efforts in the fight against major illnesses, such as cancer, heart disease, Parkinson’s disease and arthritis.
Says Chris Tierney, Director of the global Clinical Trials Logistics service at DHL Supply Chain: “Clinical research is becoming increasingly global and so is the demand for clinical trials logistics. Over the last four years, we have met this challenge by doubling our depot network while providing a consistent quality of standards, processes, capabilities and pricing. We are confident that we can play a key role in the further globalization of clinical trials to help accelerate the discovery of new and groundbreaking treatments.”
When developing a supply strategy for a global clinical study, the company carefully balances supply needs with the budget limitations that customers must deal with —reinforced by the current economic climate. Key benefits of the CTL solutions, such as depot rationalization, tax efficiency and dedicated project management, help customers to improve return on clinical investment. By doubling the number of clinical trial depots, the company has increased its capacity to support global clinical research projects, including so-called “mega-trials” in the pharmaceutical and vaccine industries. It adds value to customers’ supply chains by scaling down customers’ distribution networks into fewer supply points, which can deliver into an increasing number of geographically diverse delivery end points.
All the clinical trial depots are working to global industry quality standards. Further depots, such as a Middle East multi-market hub, may be added to the network if demand arises.
Customers from the health care industry include large- and medium-sized pharmaceutical and biotechnology companies as well as clinical research organizations. They benefit from business units working together to be able to provide all aspects required to manage a global clinical trial supply chain; from inbound transport logistics to storage, to customs brokerage and network design, right through to the final mile. Based on the Exel North America and DHL Supply Chain global presence and unrivalled transport infrastructure, the Clinical Trials team combines knowledge of import laws, regulatory insight and local expertise to design customized health care supply chains.
About Exel
Exel is the North American leader in contract logistics, providing customer-focused solutions to a wide range of industries including aerospace, automotive, chemical, consumer, energy, industrial, life sciences, retail and technology. Exel’s innovative supply chain solutions, skilled people and regional coverage, bring together all aspects of contract logistics in addition to a wide range of integrated, value-added and specialist services. Exel is a wholly owned entity of Deutsche Post DHL, the world’s leading logistics group. For more information, visit www.exel.com.
| < Prev | Next > |
|---|
